Providence Wealth Advisors, LLC Immuno Gen, Inc. Transaction History

Providence Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$5.79 - $8.6 $14,475 - $21,500	-2,500 Reduced 20.0%	10,000 $63,000
Q1 2021 May 17, 2021	SELL	$6.5 - $10.53 $3,250 - $5,265	-500 Reduced 3.85%	12,500 $101,000
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $925 - $1,915	250 Added 1.96%	13,000 $87,000
Q3 2020 Nov 10, 2020	SELL	$3.45 - $4.89 $1,725 - $2,445	-500 Reduced 3.77%	12,750 $46,000
Q2 2020 Aug 07, 2020	BUY	$3.32 - $5.34 $6,640 - $10,680	2,000 Added 17.78%	13,250 $61,000
Q1 2020 May 05, 2020	BUY	$2.12 - $6.8 $23,850 - $76,500	11,250 New	11,250 $39,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Providence Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Providence Wealth Advisors, LLC with notifications on news.